论文部分内容阅读
近年来小儿哮喘发病率在世界范围内有上升趋势,同样,在我国也是最常见的慢性病之一。但是,现有的治疗仍不能完全控制许多患儿的哮喘症状。研究表明白三烯在哮喘中起着重要作用,抗白三烯药物为目前的治疗提供了新的选择。为此,我们在临床上观察了白三烯受体拮抗剂———顺尔宁在
In recent years, the incidence of pediatric asthma in the world upward trend, the same, in our country is one of the most common chronic diseases. However, current treatment still does not completely control the asthma symptoms in many children. Studies have shown that leukotrienes play an important role in asthma and anti-leukotriene drugs offer new options for the current treatment. To this end, we observed in the clinical leukotriene receptor antagonist - Shunning in